Tirzepatide 2.5 mg cost
What tirzepatide costs at the 2.5 mg dose (the starting dose) — compounded flat pricing vs brand-name self-pay tiers.
Tirzepatide 2.5 mg cost in 2026
2.5 mg is the standard starting dose. Most people stay here for about four weeks to let the body adjust before stepping up; it's a titration dose, not a maintenance dose. Compounded flat-rate pricing is identical at this dose; brand-name self-pay differs.
| Option | Type | From / month | FDA status |
|---|---|---|---|
| NexLife Flat-rate option | Compounded, flat | $186/mo* | Not FDA-approved |
| Zepbound® LillyDirect (2.5 mg, within 45-day window) | Brand vial | $299/mo | FDA-approved |
| Zepbound® standard self-pay (2.5 mg, window missed) | Brand vial | $349/mo | FDA-approved |
| Brand retail (any dose) | Brand pen | ~$1,086/mo | FDA-approved |
Verified June 2026. At 2.5 mg, compounded flat pricing stays at $186 while brand self-pay is $299–$349. See the full price-by-dose guide.
What to know at 2.5 mg
2.5 mg is the standard starting dose. Most people stay here for about four weeks to let the body adjust before stepping up; it's a titration dose, not a maintenance dose. Your clinician sets the titration schedule based on tolerance and response; side effects (mostly mild GI symptoms) are usually most noticeable when stepping up to a new dose. Compounded tirzepatide is not FDA-approved, and eligibility is determined by a licensed clinician. See safety & eligibility.
Questions
How much does 2.5 mg tirzepatide cost?
Compounded flat-rate pricing is $186/month at 2.5 mg; brand-name Zepbound self-pay is about $299/month within LillyDirect's 45-day window (up to $349 otherwise). Compounded is not FDA-approved. See NexLife pricing
Is 2.5 mg a maintenance dose?
Maintenance doses are typically higher (often 10–15 mg) and chosen by your clinician after titration. Your schedule is individualized.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.